Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Testosterone Propionate
×
Other
×
Clear all
Filters
3
NCT00612742
2021-10-29
BLOOM
BioSante Pharmaceuticals
Phase 3
Completed
3,656 enrolled